đŹ Current Disease Focus:
Task Progress: 0%
đĽ Active Problem Solvers
0
đ Experts collaborating globally
⥠Current Task Assignment
𧏠Genetic Analysis
đ Matching experts to specific tasks
đ Resource Allocation by Research Phase:
đ Data Analysis
𧪠Experimental Design
đŹ Clinical Trials
đ Treatment Development
The purpose of this observer-blind study is to gather key efficacy, safety,...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-03-27
Trial ID
NCT00866619
This study will evaluate the immunogenicity and safety of the pertussis com...
Status
Withdrawn
Location
Multiple Locations
Start Date
2009-12
Trial ID
NCT01003431
This study will only include infants born to mothers who are tested as sero...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-10
Trial ID
NCT00317122
Treatments Being Tested
The aim of the study is to evaluate the immunogenicity, safety and reactoge...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-06-01
Trial ID
NCT01175083
Treatments Being Tested
DTaP-HB-PRP\~T combined vaccine is being developed in order to comply with ...
Status
Completed
Location
Multiple Locations
Start Date
2007-09
Trial ID
NCT00514709
Treatments Being Tested
The purpose of this study is to support the registration of the pentavalent...
Status
Completed
Location
Multiple Locations
Start Date
2006-08
Trial ID
NCT00343889
Treatments Being Tested
This purpose of the study is to assess the safety and immunogenicity of a G...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-07-07
Trial ID
NCT01098474
Treatments Being Tested
This study is being done to assess the possibility of the potential integra...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-04-30
Trial ID
NCT00436007
Treatments Being Tested
In order to reduce the amount of thiomersal in its vaccines, GSK Biological...
Status
Completed
Location
GSK Investigational Site
Start Date
2003-08
Trial ID
NCT01061541
This booster study will assess the immunogenicity, reactogenicity and safet...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-06
Trial ID
NCT00332566
Treatments Being Tested